151 related articles for article (PubMed ID: 31153594)
1. Challenges relating to the therapeutic management of neuropathic pain.
Alcántara Montero A; González Curado A
Rev Esp Anestesiol Reanim (Engl Ed); 2019 Oct; 66(8):452-453. PubMed ID: 31153594
[No Abstract] [Full Text] [Related]
2. New investigational drugs for the treatment of neuropathic pain.
Sałat K; Kowalczyk P; Gryzło B; Jakubowska A; Kulig K
Expert Opin Investig Drugs; 2014 Aug; 23(8):1093-104. PubMed ID: 24896842
[TBL] [Abstract][Full Text] [Related]
3. Voltage-gated Na+ channels in neuropathic pain.
Hargus NJ; Patel MK
Expert Opin Investig Drugs; 2007 May; 16(5):635-46. PubMed ID: 17461737
[TBL] [Abstract][Full Text] [Related]
4. New pain drugs in pipeline, but challenges to usage remain.
Brower V
J Natl Cancer Inst; 2012 Apr; 104(7):503-5. PubMed ID: 22440682
[No Abstract] [Full Text] [Related]
5. The evolving nature of neuropathic pain: individualizing assessment and treatment. Introduction.
Nicholson B
Eur J Pain; 2002; 6 Suppl B():1. PubMed ID: 23570141
[No Abstract] [Full Text] [Related]
6. Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers.
Kushnarev M; Pirvulescu IP; Candido KD; Knezevic NN
Expert Opin Investig Drugs; 2020 Mar; 29(3):259-271. PubMed ID: 32070160
[No Abstract] [Full Text] [Related]
7. CHI's Eighth Annual World Pharmaceutical Congress. Targeting pain with novel therapeutics: Part 1.
Foster K
IDrugs; 2009 Aug; 12(8):478-81. PubMed ID: 19629879
[No Abstract] [Full Text] [Related]
8. Emerging drugs for neuropathic pain.
Gilron I; Dickenson AH
Expert Opin Emerg Drugs; 2014 Sep; 19(3):329-41. PubMed ID: 24793304
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
10. What can we learn from failed neuropathic pain trials?
Polydefkis M; Raja SN
Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
[No Abstract] [Full Text] [Related]
11. Emerging trends in the management of neuropathic pain.
McCleane G
Expert Rev Neurother; 2005 Sep; 5(5):617-23. PubMed ID: 16162085
[TBL] [Abstract][Full Text] [Related]
12. Neural tissue engineering scaffold with sustained RAPA release relieves neuropathic pain in rats.
Ding T; Zhu C; Kou ZZ; Yin JB; Zhang T; Lu YC; Wang LY; Luo ZJ; Li YQ
Life Sci; 2014 Sep; 112(1-2):22-32. PubMed ID: 25050464
[TBL] [Abstract][Full Text] [Related]
13. Selective Na
Bankar G; Goodchild SJ; Howard S; Nelkenbrecher K; Waldbrook M; Dourado M; Shuart NG; Lin S; Young C; Xie Z; Khakh K; Chang E; Sojo LE; Lindgren A; Chowdhury S; Decker S; Grimwood M; Andrez JC; Dehnhardt CM; Pang J; Chang JH; Safina BS; Sutherlin DP; Johnson JP; Hackos DH; Robinette CL; Cohen CJ
Cell Rep; 2018 Sep; 24(12):3133-3145. PubMed ID: 30231997
[TBL] [Abstract][Full Text] [Related]
14. Toward a definition of pharmacoresistant neuropathic pain.
Hansson PT; Attal N; Baron R; Cruccu G
Eur J Pain; 2009 May; 13(5):439-40. PubMed ID: 19324579
[No Abstract] [Full Text] [Related]
15. Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial.
Carmland ME; Kreutzfeldt M; Holbech JV; Andersen NT; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
Trials; 2019 Oct; 20(1):588. PubMed ID: 31604475
[TBL] [Abstract][Full Text] [Related]
16. Na
McKerrall SJ; Sutherlin DP
Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
[TBL] [Abstract][Full Text] [Related]
17. No gain, no pain: NaV1.7 as an analgesic target.
King GF; Vetter I
ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial.
de Leeuw TG; Mangiarini L; Lundin R; Kaguelidou F; van der Zanden T; Pasqua OD; Tibboel D; Ceci A; de Wildt SN;
Trials; 2019 Jan; 20(1):49. PubMed ID: 30646965
[TBL] [Abstract][Full Text] [Related]
19. The neuropathic pain: An overview of the current treatment and future therapeutic approaches.
Cavalli E; Mammana S; Nicoletti F; Bramanti P; Mazzon E
Int J Immunopathol Pharmacol; 2019; 33():2058738419838383. PubMed ID: 30900486
[TBL] [Abstract][Full Text] [Related]
20. Pain therapeutics--SMi's Ninth Annual Conference 8-9 June 2009, London, UK.
Kirkham K
IDrugs; 2009 Aug; 12(8):489-91. PubMed ID: 19629882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
